Document Detail


Masked hypertension: evidence of the need to treat.
MedLine Citation:
PMID:  20694858     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The diagnosis of masked hypertension has been made easier with the widespread availability of home blood pressure monitoring devices with levels of accuracy comparable to ambulatory blood pressure monitoring. The negative impact of masked hypertension on cardiovascular morbidity and mortality is evidenced by numerous well-designed clinic-based and population-based studies. The relationship of masked hypertension and target organ damage is also well documented. These two factors, combined with the robust evidence of reduced cardiovascular morbidity and mortality achieved with blood pressure treatment, makes the argument for actively identifying patients with masked hypertension and prescribing treatment similar to that for patients with sustained hypertension. In this paper, we review the evidence for the cardiovascular prognosis of masked hypertension compared with sustained hypertension, we review its impact on target organ damage, we propose an algorithm for the treatment of patients with masked hypertension, and we point out the pitfalls in adopting such an approach.
Authors:
Gbenga Ogedegbe; Charles Agyemang; Joseph E Ravenell
Related Documents :
18447098 - Hypertension knowledge among patients from an urban clinic.
8659638 - Natural history of male psychological health, xiii: who develops high blood pressure an...
2365448 - "structural factor" in primary and secondary hypertension.
6827318 - The blood-brain barrier following experimental subarachnoid hemorrhage. part 1: respons...
15204388 - Biomechanical properties of the anterior urethra of the male rabbit--a study using impe...
11881128 - Effects of candesartan on cardiac and arterial structure and function in hypertensive s...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current hypertension reports     Volume:  12     ISSN:  1534-3111     ISO Abbreviation:  Curr. Hypertens. Rep.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-20     Completed Date:  2011-02-03     Revised Date:  2014-09-19    
Medline Journal Info:
Nlm Unique ID:  100888982     Medline TA:  Curr Hypertens Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  349-55     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Algorithms
Antihypertensive Agents / therapeutic use
Blood Pressure Monitoring, Ambulatory*
Cardiovascular Diseases / epidemiology,  etiology,  prevention & control*
Child
Diagnosis, Differential
Humans
Hypertension / complications,  diagnosis*,  epidemiology*,  physiopathology,  therapy*
Observer Variation
Risk Assessment
Treatment Outcome
Grant Support
ID/Acronym/Agency:
R01 HL078566/HL/NHLBI NIH HHS; R01 HL078566/HL/NHLBI NIH HHS; R01 HL087301/HL/NHLBI NIH HHS; R01 HL087301/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Antihypertensive Agents
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New model to explain the EQ-5D VAS in patients who have undergone spinal fusion.
Next Document:  The impact of experienced emotion on evaluative judgments: the effects of age and emotion regulation...